TGFB1 and neoplasm: Although it has been shown that TGF-β plays an inhibitory, anti-tumor role in early cancer stages, recent studies have revealed that TGF-β also displays cancer-promoting properties, including the impairment of NK function, which in turn enhances tumorigenesis and metastasis while inducing immunosuppression and drug resistance [12,37].